Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells for Steroid-Resistant GVHD
NCT00314483Phase 2Unknown
- Sponsor
- Christian Medical College, Vellore
- Start
- Jun 2007
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mesenchymal stem cells in graft-versus-host disease (GVHD), sponsored by Christian Medical College, Vellore. Primary endpoint: Control of Graft Versus Host Disease at 8 weeks. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00314483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314483.